Clinical Trial: Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

U.S., Nov. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07228832) titled 'Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer' on Nov. 10.

Brief Summary: A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with mFOLFOX6 (Oxaliplatin, Leucovorin and 5-Fluorouracil) versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer(HARMONi-GI3)

Study Start Date: Nov. 15

Study Type: INTERVENTIONAL

Condition: Metastatic Colorectal Cancer (CRC)

Intervention: DRUG: Drug: Ivonescimab Injection

Subjects will receive Ivonescimab Plus mFOLFOX6 (Oxal...